Xenon-129: Clinical Trials

3 trials of Xenon-129, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 withdrawn. 2 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Recruiting 1
Not applicable1Withdrawn 1
Phase 11Active not recruiting 1

Follow Xenon-129: new trials by email Literature Review of Xenon-129 trials Research Report on Xenon-129

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients
Xenon-129 - Thoracic Insufficiency Syndrome
Not applicableWithdrawnPatrick Cahill, MD2026-01-012026-03-05
Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
Xenon-129 - ILD
Phase 1 / Phase 2Active not recruitingChildren's Hospital Medical Center, Cincinnati782022-04-142026-02-13
Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease
Xenon-129 and Perfluoropropane (19F), Magnetic Resonance Imaging, Lung Clearance Index - Cystic Fibrosis, Asthma
Phase 2RecruitingThe Hospital for Sick Children302015-08-012026-03-02

Conditions studied

Asthma (1)  ·  Cystic Fibrosis (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (1)  ·  Patrick Cahill, MD (1)  ·  The Hospital for Sick Children (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Giles Santyr, PhD (1)  ·  Patrick Cahill, MD (1)  ·  Zack Cleveland, PhD (1)

Results publications

PMID 28245140, PMID 33303537